Published in Blood on February 01, 1987
Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med (1989) 2.72
Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol (2011) 2.17
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med (1994) 2.00
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80
Antibiotic proteins of human neutrophils. J Clin Invest (1990) 1.67
Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect Immun (1990) 1.64
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest (1990) 1.46
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest (1995) 1.29
Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol (1995) 1.24
Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest (1990) 1.18
The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta (2007) 1.14
Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury. Infect Immun (1994) 0.99
Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles. Infect Immun (1988) 0.98
Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein. Ann Surg (1995) 0.98
Neutrophils and macrophages: the main partners of phagocyte cell systems. Front Immunol (2012) 0.97
Modulation of lipopolysaccharide binding to human granulocytes. Immunology (1994) 0.89
Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol (1999) 0.86
Detecting distant relatives of mammalian LPS-binding and lipid transport proteins. Protein Sci (1998) 0.86
Crucial genes and pathways in chicken germ stem cell differentiation. J Biol Chem (2015) 0.86
Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis. Antimicrob Agents Chemother (1996) 0.84
Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun (2006) 0.81
Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infect Immun (1995) 0.79
Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery. Antimicrob Agents Chemother (2006) 0.76
Bactericidal/permeability-increasing protein attenuates systemic inflammation and acute lung injury in porcine lower limb ischemia-reperfusion injury. Ann Surg (2001) 0.75
Resistance to Antimicrobial Peptides in Vibrios. Antibiotics (Basel) (2014) 0.75
Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties. Ann Surg (1999) 0.75
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Metal chelate affinity chromatography, a new approach to protein fractionation. Nature (1975) 5.83
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Subcutaneous sterile water injections for chronic neck and shoulder pain following whiplash injuries. Lancet (1993) 3.63
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15
Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest (1980) 2.99
Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest (1975) 2.97
A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1998) 2.85
An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br J Haematol (1991) 2.74
The decision to breastfeed in the United States: does race matter? Pediatrics (2001) 2.67
Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J (1999) 2.65
The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem (1974) 2.65
Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology (2002) 2.49
A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes. Rev Infect Dis (1983) 2.35
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29
Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem (1989) 2.29
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood (1974) 2.22
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest (1975) 2.16
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther (2013) 2.15
Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol (1996) 2.09
Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun (1976) 2.05
Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest (1985) 2.05
Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system. J Clin Invest (1982) 2.04
An evolving view of Saturn's dynamic rings. Science (2010) 1.99
Latex sensitization in health care workers and in the US general population. Am J Epidemiol (2001) 1.98
Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem (2001) 1.98
Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest (1983) 1.93
The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem (1973) 1.92
Retracted On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest (1991) 1.89
Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis. Proc Natl Acad Sci U S A (2007) 1.86
A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem (1987) 1.86
Myeloperoxidase-mediated iodination in granulocytes. Scand J Haematol (1972) 1.83
Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med (1974) 1.82
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
A simple method for measuring red cell deformability in models of the microcirculation. Blut (1973) 1.75
Prevention of pedestrian injuries to children: effectiveness of a school training program. Pediatrics (1991) 1.72
Intermittent dislocation flow in viscoplastic deformation. Nature (2001) 1.71
Radioimmunoassay of human eosinophil cationic protein. Br J Haematol (1977) 1.68
The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol (1984) 1.67
Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest (1990) 1.67
Acceleration of wound healing by topical application of honey. An animal model. Am J Surg (1983) 1.66
Source of bias in prenatal care utilization indices: implications for evaluating the Medicaid expansion. Am J Public Health (1991) 1.63
Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA (1981) 1.62
Heart rate variability. Frequency domain analysis. Cardiol Clin (1992) 1.60
Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+. Proc Natl Acad Sci U S A (1990) 1.60
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia (1998) 1.56
Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 1.56
The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest (1996) 1.54
Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology (1982) 1.53
Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest (1990) 1.52
Antimicrobial peptides of phagocytes and epithelia. Semin Hematol (1997) 1.50
Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest (1985) 1.50
Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol (1998) 1.49
Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem (1993) 1.48
The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology (1993) 1.48
Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein. Infect Immun (1986) 1.48
Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol (1989) 1.44
Selective block of urethral sphincter contraction using a modified Brindley electrode in sacral anterior root stimulation of the dog. Neurourol Urodyn (2002) 1.43
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol (1988) 1.43
Isolation and characterization of a phospholipase A2 from an inflammatory exudate. J Lipid Res (1978) 1.42
Bidirectional movement of a nascent polypeptide across microsomal membranes reveals requirements for vectorial translocation of proteins. Cell (1992) 1.41
Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun (1976) 1.41
Detection of fungi in tissue sections by lectin histochemistry. Arch Pathol Lab Med (1988) 1.41
Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction. Biochim Biophys Acta (1976) 1.39
[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. Hautarzt (1997) 1.38
Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol (1989) 1.38
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine (1990) 1.35
Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34
Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology (1994) 1.33
Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun (1997) 1.33
A tail electrode for unrestrained rats. J Exp Anal Behav (1967) 1.33
Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int (2002) 1.33
Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology (1995) 1.33
Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem (1990) 1.32
Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol (1994) 1.31
Dorsoventral patterning in the Drosophila central nervous system: the vnd homeobox gene specifies ventral column identity. Genes Dev (1998) 1.30
Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis (2011) 1.30
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest (1995) 1.29
Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest (1975) 1.28
Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. Lancet (1986) 1.26
Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions. J Biol Chem (2000) 1.26
Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol (1977) 1.25
Influence of nuclear selection criteria on sex chromatin frequency in oral mucosa cells of newborn females. Cytogenetics (1967) 1.25
Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr Opin Immunol (1993) 1.23
Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.23
Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol (2000) 1.22
Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol (1981) 1.20
Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. J Clin Pathol (1988) 1.20
An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci U S A (1997) 1.19
Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils. Infect Immun (1982) 1.19